obesity
Conditions
Interventions
Wuzhi jiaonang Experimental group:Behavioural intervention for 4 weeks with concomitant administration of wuzhi jiaonang (National Drug Code Z10983013 Sichuan Hezheng Pharmaceutical 4 capsules/dose 3
Sponsors
Shanghai Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-60 years old; 2. Meeting the diagnostic criteria for overweight or obesity with a BMI = 24 kg/m2; 3. Not allergic to Schisandrae Chinensis Fructus fractions; 4. Good treatment compliance and cooperation in completing the study; 5. Willingness to participate in this study and sign an informed consent form. All of the above conditions must be met to be included in this study.
Exclusion criteria
Exclusion criteria: 1. Patients with secondary or medical obesity such as obesity caused by abnormal function of gonadal axis adrenal axis thyroid axis and obesity caused by glucocorticoids and other medications; 2. Pregnant and breastfeeding women; 3. Patients with severe cardiovascular and cerebral vascular diseases or hepatic and renal failure; 4. Patients with severe infection/ketosis within the past 3 months; 5. Patients who have undergone bariatric surgery in the past 1 year; 6. Patients who have lost more than 10 % of their body weight in the past 3 months; 7. Other conditions that are not suitable for inclusion. If any of the above conditions exists it is not allowed to be included in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| body fat mass;Decrease in body weight;Changes in the BSH enzyme-associated flora of Lactobacillus et al;Decrease in body mass index;GCA and other conjugated bile acids; | — |
Secondary
| Measure | Time frame |
|---|---|
| LDL-C;liver function;TC;TG; | — |
Countries
China
Contacts
Public ContactFeng Tao
Shanghai Traditional Chinese Medicine Hospital
Outcome results
None listed